FDA Inspection 922071 — UCB Biosciences Inc.

UCB Biosciences Inc. — FEI 3011290762

The FDA completed an inspection of UCB Biosciences Inc. on Mar 19, 2015 in Smyrna, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 19, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Smyrna, GA (United States)

Additional Details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.